Humacyte, Inc. (HUMA) Reports In-Line Q4 EPS

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $1.35 million.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Crude Inventory Rose 3 Million Barrels Last Week - EIA
• Active options: META MSTR MU MSFT INTC GOOGL DELL SOFI NFLX RIVN MRVL
• Increasing unusual call volume: MULL RSP NRG CPRX FBTC JACK VERA OTLK